Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Gihan S. Labib & Ragwa M. Farid. (2015) Osteogenic effect of locally applied Pentoxyfilline gel: in vitro and in vivo evaluations. Drug Delivery 22:8, pages 1094-1102.
Read now
Read now
Mahesh R Dabhi & Navin R. Sheth. (2013) Formulation development of physiological environment responsive periodontal drug delivery system for local delviery of metronidazole benzoate. Drug Development and Industrial Pharmacy 39:3, pages 425-436.
Read now
Read now
Kazuhiro Imai. (2013) Alendronate sodium hydrate (oral jelly) for the treatment of osteoporosis: review of a novel, easy to swallow formulation. Clinical Interventions in Aging 8, pages 681-688.
Read now
Read now
Articles from other publishers (36)
Subash Chandra Raj, Asit Kumar Mishra, Devapratim Mohanty, Neelima Katti, Snigdha Pattnaik, Laxmikanta Patra & Abinash Pattanaik. (2023) Comparative evaluation of the clinical and radiographic efficacy of 0.05% zoledronate gel as local drug delivery system in treating intrabony defects in stage III grade B periodontitis patients with and without type‐2 diabetes mellitus—A randomized split‐mouth clinical trial. Clinical Advances in Periodontics.
Crossref
Crossref
Malkiet Kaur, Manju Nagpal & Geeta Aggarwal. (2023) Nanotechnology for Targeted Drug Delivery to Treat Osteoporosis. Current Drug Targets 24:1, pages 2-12.
Crossref
Crossref
Claudia Arena, Vito Carlo Alberto Caponio, Khrystyna Zhurakivska, Lucio Lo Russo, Lorenzo Lo Muzio & Giuseppe Troiano. (2022) Added effect of 1% topical alendronate in intra-bony and inter-radicular defects as part of step II periodontal therapy: a systematic review with meta-analysis and trial sequential analysis. BMC Oral Health 22:1.
Crossref
Crossref
Shweta Gupta, Paras Gupta, Nikita Raman, Anshdeep Singh, Amit Shah & Vikas Ramola. (2022) Comparison between Different Combinations of Alendronate, Platelet-rich Fibrin, Hydroxyapatite in Bone Regeneration in Endodontic Surgeries Using Cone-beam Computed Tomography. The Journal of Contemporary Dental Practice 23:3, pages 337-342.
Crossref
Crossref
Hana A. Tokhtah & Adel M. Alhadlaq. (2022) Utility of injectable bisphosphonates in enhancing orthodontic retention in a goat model: A split-mouth study. The Saudi Dental Journal 34:4, pages 282-287.
Crossref
Crossref
Bhavya Shetty, Pallavi Karegowda, SafiyaFatima Khan, Umesh Yadalam & Manjusha Nambiar. (2022) Comparison of simvastatin 1.2% gel and alendronate 1% gel in chronic periodontitis as local drug delivery: A randomized clinical trial. Journal of Indian Society of Periodontology 26:6, pages 591.
Crossref
Crossref
Jéssica S. Barbosa, Filipe A. Almeida Paz & Susana Santos Braga. (2021) Bisphosphonates, Old Friends of Bones and New Trends in Clinics. Journal of Medicinal Chemistry 64:3, pages 1260-1282.
Crossref
Crossref
Natália de Campos Kajimoto, Yvonne de Paiva Buischi, Peter Michael Loomer, Timothy G. Bromage, Edilson Ervolino, Stephen Enrico Fucini, Natália Marcumini Pola, Beatriz Ommati Pirovani, Maria Juliana Sismeiro Morábito, Juliano Milanezi de Almeida, Flávia Aparecida Chaves Furlaneto & Maria José Hitomi Nagata. (2021) Adjuvant therapy with 1% alendronate gel for experimental periodontitis treatment in rats. Journal of Periodontal & Implant Science 51:6, pages 374.
Crossref
Crossref
Jéssica S. Barbosa, Susana Santos Braga & Filipe A. Almeida Paz. (2020) Empowering the Medicinal Applications of Bisphosphonates by Unveiling their Synthesis Details. Molecules 25:12, pages 2821.
Crossref
Crossref
UrvashiOjha Tiwari, Ramesh Chandra, Supratim Tripathi, Jyoti Jain, Sanjay Jaiswal & RahulKumar Tiwari. (2020) Comparative analysis of platelet.rich fibrin, platelet-rich fibrin with hydroxyapatite and platelet-rich fibrin with alendronate in bone regeneration: A cone-beam computed tomography analysis. Journal of Conservative Dentistry 23:4, pages 348.
Crossref
Crossref
Ishita Wanikar, Surekha Rathod & Abhay P. Kolte. (2019) Clinico-radiographic evaluation of 1% alendronate gel as an adjunct and smart blood derivative platelet rich fibrin in grade II furcation defects. Journal of Periodontology 90:1, pages 52-60.
Crossref
Crossref
Bruno Fonseca-Santos & Marlus Chorilli. (2018) An overview of polymeric dosage forms in buccal drug delivery: State of art, design of formulations and their in vivo performance evaluation. Materials Science and Engineering: C 86, pages 129-143.
Crossref
Crossref
J. Anjana, Annapoorna Mohandas, S. Seethalakshmy, Maneesha K. Suresh, Riju Menon, Raja Biswas & R. Jayakumar. (2018) Bi-layered nanocomposite bandages for controlling microbial infections and overproduction of matrix metalloproteinase activity. International Journal of Biological Macromolecules 110, pages 124-132.
Crossref
Crossref
Flávia A.C. Furlaneto, Nara L.T. Nunes, Ricardo B. Souza, Kely O. Yamamoto, Ivan Lima Oliveira Filho, Nicolly P.R. Frota, Hellíada Chaves, Mario Lisboa, Mario Taba Jr.Edilson Ervolino & Michel R. Messora. (2018) Local administration of Tiludronic Acid downregulates important mediators involved in periodontal tissue destruction in experimental periodontitis in rats. Archives of Oral Biology 88, pages 1-9.
Crossref
Crossref
Lawrence A. Trissel, Lisa D. Ashworth & Jay Ashworth. 2018. Trissel’s Stability of Compounded Formulations, 6e. Trissel’s Stability of Compounded Formulations, 6e.
Nara L. T. NunesMichel R. MessoraLuiz Fernando OliveiraMario LisboaMarina Costa Barcellos GarciaRodrigo O. C. C. RêgoArthur Belém NovaesJuniorJuniorSérgio Luís Scombatti de SouzaEdilson ErvolinoFlávia A. C. Furlaneto. (2017) Effects of Local Administration of Tiludronic Acid on Experimental Periodontitis in Diabetic Rats. Journal of Periodontology, pages 1-19.
Crossref
Crossref
Avani R. Pradeep, Dharmendra Kanoriya, Sandeep Singhal, Vibhuti Garg, Balaji Manohar & Anirban Chatterjee. (2017) Comparative evaluation of subgingivally delivered 1% alendronate versus 1.2% atorvastatin gel in treatment of chronic periodontitis: a randomized placebo-controlled clinical trial. Journal of Investigative and Clinical Dentistry 8:3, pages e12215.
Crossref
Crossref
Bernardo Carvalho DUTRA, Alcione Maria Soares Dutra OLIVEIRA, Peterson Antônio Dutra OLIVEIRA, Flavio Ricardo MANZI, Sheila Cavalca CORTELLI, Luís Otávio de Miranda COTA & Fernando Oliveira COSTA. (2017) Effect of 1% sodium alendronate in the non-surgical treatment of periodontal intraosseous defects: a 6-month clinical trial. Journal of Applied Oral Science 25:3, pages 310-317.
Crossref
Crossref
Anuj SHARMA, Achala RAMAN & Avani Raju PRADEEP. (2017) Role of 1% alendronate gel as adjunct to mechanical therapy in the treatment of chronic periodontitis among smokers. Journal of Applied Oral Science 25:3, pages 243-249.
Crossref
Crossref
Dharmendra KanoriyaA.R. PradeepVibhuti GargSandeep Singhal. (2017) Mandibular Degree II Furcation Defects Treatment With Platelet-Rich Fibrin and 1% Alendronate Gel Combination: A Randomized Controlled Clinical Trial. Journal of Periodontology 88:3, pages 250-258.
Crossref
Crossref
Anna K. Hiltunen, Malena E. Skogman, Kirsi Rosenqvist, Helka Juvonen, Petri Ihalainen, Jouko Peltonen, Anne Juppo & Adyary Fallarero. (2016) Bioactive glass combined with bisphosphonates provides protection against biofilms formed by the periodontal pathogen Aggregatibacter actinomycetemcomitans. International Journal of Pharmaceutics 501:1-2, pages 211-220.
Crossref
Crossref
M.B. Guimarães, R.S. Bueno, M.B.G. Blaya, R.S.A. Shinkai & L.M.H. Marques. (2015) Influence of the local application of sodium alendronate gel on osseointegration of titanium implants. International Journal of Oral and Maxillofacial Surgery 44:11, pages 1423-1429.
Crossref
Crossref
Urszula Posadowska, Martin Parizek, Elena Filova, Malgorzata Wlodarczyk-Biegun, Marleen Kamperman, Lucie Bacakova & Elzbieta Pamula. (2015) Injectable nanoparticle-loaded hydrogel system for local delivery of sodium alendronate. International Journal of Pharmaceutics 485:1-2, pages 31-40.
Crossref
Crossref
Ralf Smeets, Henning Hanken, Ole Jung & Max Heiland. 2015. Medication-Related Osteonecrosis of the Jaws. Medication-Related Osteonecrosis of the Jaws
207
215
.
Flávia A.C. Furlaneto, Nara L.T. Nunes, Ivan L. Oliveira Filho, Nicolly P.R. Frota, Kely O. Yamamoto, Mario R.P. Lisboa, Edilson Ervolino, Mario TabaJr.Jr., Rodrigo Otávio Rêgo & Michel R. Messora. (2014) Effects of Locally Administered Tiludronic Acid on Experimental Periodontitis in Rats. Journal of Periodontology 85:9, pages 1291-1301.
Crossref
Crossref
A.R. Pradeep, Minal Kumari, Nishanth S. Rao & Savitha B. Naik. (2013) 1% Alendronate Gel as Local Drug Delivery in the Treatment of Class II Furcation Defects: A Randomized Controlled Clinical Trial. Journal of Periodontology 84:3, pages 307-315.
Crossref
Crossref
Aino-Liisa Alanne, Manu Lahtinen, Miika Löfman, Petri Turhanen, Erkki Kolehmainen, Jouko Vepsäläinen & Elina Sievänen. (2013) First bisphosphonate hydrogelators: potential composers of biocompatible gels. Journal of Materials Chemistry B 1:45, pages 6201.
Crossref
Crossref
A. R. Pradeep, Anuj Sharma, Nishanth S. Rao, Pavan Bajaj, Savitha B. Naik & Minal Kumari. (2012) Local Drug Delivery of Alendronate Gel for the Treatment of Patients With Chronic Periodontitis With Diabetes Mellitus: A Double-Masked Controlled Clinical Trial. Journal of Periodontology 83:10, pages 1322-1328.
Crossref
Crossref
Tommaso Iannitti, Stefano Rosini, Daniele Lodi, Bruno Frediani, Valentina Rottigni & Beniamino Palmieri. (2012) Bisphosphonates. American Journal of Therapeutics 19:3, pages 228-246.
Crossref
Crossref
Anuj Sharma & A.R. Pradeep. (2012) Clinical Efficacy of 1% Alendronate Gel in Adjunct to Mechanotherapy in the Treatment of Aggressive Periodontitis: A Randomized Controlled Clinical Trial. Journal of Periodontology 83:1, pages 19-26.
Crossref
Crossref
Anuj Sharma & A.R. Pradeep. (2012) Clinical Efficacy of 1% Alendronate Gel as a Local Drug Delivery System in the Treatment of Chronic Periodontitis: A Randomized, Controlled Clinical Trial. Journal of Periodontology 83:1, pages 11-18.
Crossref
Crossref
Falk Wehrhan, Peter Hyckel, Arndt Guentsch, Emeka Nkenke, Phillip Stockmann, Karl A Schlegel, Friedrich W Neukam & Kerstin Amann. (2011) Bisphosphonate-associated osteonecrosis of the jaw is linked to suppressed TGFβ1-signaling and increased Galectin-3 expression: A histological study on biopsies. Journal of Translational Medicine 9:1.
Crossref
Crossref
F Wehrhan, P Hyckel, K Amann, J Ries, P Stockmann, KA Schlegel, FW Neukam & E Nkenke. (2011) Msx‐1 is suppressed in bisphosphonate‐exposed jaw bone analysis of bone turnover‐related cell signalling after bisphosphonate treatment. Oral Diseases 17:4, pages 433-442.
Crossref
Crossref
Antonio Carlos Victor Canettieri, Carlos Eduardo Dias Colombo, Chung Man Chin & Horácio Faig-Leite. (2009) Femur bone repair in ovariectomized rats under the local action of alendronate, hydroxyapatite and the association of alendronate and hydroxyapatite. International Journal of Experimental Pathology 90:5, pages 520-526.
Crossref
Crossref
Matthew R. Allen & David B. Burr. (2009) The Pathogenesis of Bisphosphonate-Related Osteonecrosis of the Jaw: So Many Hypotheses, So Few Data. Journal of Oral and Maxillofacial Surgery 67:5, pages 61-70.
Crossref
Crossref
Ana Lia Anbinder, Fernanda de Almeida Prado, Marcela de Almeida Prado, Ivan Balducci & Rosilene Fernandes da Rocha. (2007) The influence of ovariectomy, simvastatin and sodium alendronate on alveolar bone in rats. Brazilian Oral Research 21:3, pages 247-252.
Crossref
Crossref